gastrointestinal therapeutics in asia-pacific markets to 2019 - strong potential for pipeline...
TRANSCRIPT
www.MarketResearchReports.com
Gastrointestinal Therapeutics in
Asia-Pacific Markets to 2019 - Strong
Potential for Pipeline Biologics on Account
of High Regional Unmet Need
Category : Defence / C2/C4ISR
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Introduction to Report
Launch Date: January 31, 2014
Number of Pages: 86
Geography Coverage: Asia Pacific
Available Format: PDF
Price For Single User License: USD 3,500
Price For Site License: USD 7,000
Price For Global User License: USD 10,500
Delivery Time: Within 24 Hours (During Working Days)
www.MarketResearchReports.com
About the Report
"Gastrointestinal Therapeutics in Asia-Pacific Markets to 2019 - Strong Potential for Pipeline Biologics on Account of High Regional Unmet Need", which provides insights into three therapeutic indications in gastrointestinal disorders in Asia-Pacific (APAC) markets of India, China, Japan and Australia.
The report provides an in-depth analysis of the therapeutic indications of gastrointestinal disorders, namely Irritable Bowel Syndrome (IBS), Ulcerative Colitis (UC) and Crohn’s Disease (CD).
www.MarketResearchReports.com
Research Findings
The gastrointestinal (GI) therapeutics market for Irritable Bowel Syndrome (IBS), Ulcerative Colitis (UC) and Crohn’s Disease (CD) in the Asia-Pacific (APAC) region will increase in value from $564m in 2012 to $784m by 2019, at a Compound Annual Growth Rate (CAGR) of 4.8%.
The latest report states that in the APAC region, comprising Australia, India, China and Japan, India will experience the fastest growth during the forecast period, with a higher CAGR of 7.7%. This will be followed by the Chinese market, which is expected to achieve a CAGR of 6.4%.
This increase will occur at a time when the global GI market value is anticipated to decline from $6.8 billion in 2012 to $6.6 billion by 2019, at a negative CAGR of 0.3%, due to major patent expiries.
www.MarketResearchReports.com
Scope
Disease overview and treatment usage patterns
Market size and forecast for IBS, UC and CD in APAC market from 2012 to 2019
Major marketed products for the indications types covered
In-depth pipeline analysis for IBS, UC and CD
Key drivers and restraints that have had and are expected to have a significant impact upon the market
Key licensing and co-development agreements in the gastrointestinal therapeutics market
www.MarketResearchReports.com
Report Coverage
1. Table of Contents2. Gastrointestinal Therapeutics in Asia-Pacific Market –
Introduction3. Gastrointestinal Therapeutics in Asia-Pacific Market –
Marketed Products (Global)4. Gastrointestinal Therapeutics in Asia-Pacific Market –
Pipeline Analysis5. Gastrointestinal Therapeutics in Asia-Pacific Market –
Market Forecast to 20196. Gastrointestinal Therapeutics in Asia-Pacific Market –
Deals and Strategic Consolidations (Global)7. Gastrointestinal Therapeutics in Asia-Pacific Market –
Appendix
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.
www.MarketResearchReports.com
Custom Research: Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let us know your specific research requirements. Our goal is to cater to your requirements be it for a custom market research project, syndicated research report on a specific market or industry sector, newsletter creation, case study development or anything else related to marketing research.
For Any Customization Related query Visit IdeaCenter @http://www.marketresearchreports.com/idea-center
www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and purchase this publication:
http://www.marketresearchreports.com/gbi-research/gastrointestinal-therapeutics-asia-pacific-markets-2019-strong-potential-pipeline
About Market Research Reports, Inc.Market Research Reports provides a customized set of reports from reputed Publishers, built on the intelligence available within organizations and leverages on our motto of “Intelligence Redefined”.
Contact : Amitava SenEmail : [email protected]: +1 302-703-7787 (USA) +91-8762746600 (India)